Objective: To study the efficiency of treatment via single administration of high-purity 89Sr chloride in the standard activity of 150 MBq for pain syndrome in patients with multiple bone metastases.
Subjects And Methods: The authors carried out clinical trials of high-purity 89Sr chloride used to treat 30 patients with multiple bone metastases from cancers at various sites. The results of treatment were analyzed in 30 patients with multiple bone metastases, who had received systemic radiation therapy with high-purity 89Sr chloride in the standard activity of 150 MBq. These were assessed using some indicators: the intensity of pain syndrome and the blood concentrations of hemoglobin, leukocytes, and platelets.
Results: There was evidence for the use of high-purity 89Sr chloride in the therapy of patients with cancer at various sites with multiple bone metastases. The major indicators (pain syndrome, the blood concentrations of hemoglobin, leukocytes, and platelets) were compared before and after the treatment. These were also compared with those obtained with the use of usual 89Sr chloride.
Conclusion: The therapeutic action of high-purity 89Sr chloride is comparable with that of 89Sr chloride in the standard activity; moreover, the analgesic effect of high-purity 89Sr chloride is being significantly higher. It has less significant myelotoxic activity than usual 89Sr chloride. High-purity 89Sr chloride is an effective radiopharmaceutical agent and may be used for systemic radiotherapy in patients with multiple bone metastatic lesion.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Radiochemical quality control of the radiopharmaceutical, SrCl produced in FBTR.
Appl Radiat Isot
February 2023
MC&MFCG, Indira Gandhi Centre for Atomic Research, HBNI, Kalpakkam, 603102, India.
SrCl radiopharmaceuticals is mainly used for bone pain palliation in the cancer patients, is being produced in FBTR via Y(n, p)Sr using yttria target. The irradiated yttria target is chemically processed in high pure quartz distilled nitric acid medium in hot cell facility, to avoid the corrosion of components of hotcell due to chloride ions while using HCl medium. Being ionic species, the purified Sr(II) cation in aqueous solution containing bulk nitrate and other trace anions, exists as SrX species where X: F, Cl, Br, NO, PO and SO, n: stoichiometric anion content.
View Article and Find Full Text PDFAdded value of hybrid SPECT with CT imaging for predicting poor therapeutic efficacy of Sr in patients with bone metastasis.
Sci Rep
December 2020
Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China.
To utilize single-photon emission computed tomography/computed tomography (SPECT/CT) scanning to investigate the usefulness of nerve root compression (NRC) and radioactive cold zone lesions (RCZLs) for predicting poor therapeutic efficacy of strontium-89 chloride (Sr-89) in patients with bone metastasis. Patients with bone metastatic neoplasms who had undergone baseline bone SPECT/CT scanning before Sr-89 therapy (148 MBq Sr-89 chloride by an intravenous injection for each patient) between July 2011 and July 2018 were included. Bone SPECT/CT images were assessed by two readers independently.
View Article and Find Full Text PDFMonitoring and Handing of 89Sr Injection Site Extravasation in a Patient With Breast Cancer.
Clin Nucl Med
July 2020
From the Department of Nuclear Medicine, Zigong First People's Hospital, Zigong, Sichuan, China.
Extravasation of various imaging tracers during administration was not a rare complication during nuclear medicine practice. However, the occurrence of extravasation of therapeutic radiopharmaceutical was rarely reported. Here we reported a 60-year-old woman with breast cancer and diffuse painful bone metastases who received strontium chloride (SrCl2) therapy to palliate her bone pain.
View Article and Find Full Text PDFComparative studies on the potential use of Lu-based radiopharmaceuticals for the palliative therapy of bone metastases.
Int J Radiat Biol
June 2020
Department of Experimental Physics, Institute of Physics and Technology, Ural Federal University, Yekaterinburg, Russia.
In recent years, radionuclides like Lu have been considered promising material for the creation of therapeutic radiopharmaceuticals. With the therapeutic use of radiopharmaceuticals, the absorbed doses per tumor may exceed 10 Gy. It is extremely important that doses absorbed by healthy organs and tissues do not exceed the threshold for the incidence of deterministic effects.
View Article and Find Full Text PDF[Efficacy of 89Sr as Pain Relief for Gastric Cancer Bone Metastasis].
Gan To Kagaku Ryoho
April 2019
Dept. of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center.
We experienced 2 cases in which strontium chloride was used for pain associated with gastric cancer bone metastasis. Case 1 was of a 69-year-old woman. In 2015, she underwent surgery for advanced gastric cancer followed by adjuvant chemotherapy with S-1 for 1 year.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!